SOD1 and diabetes mellitus: Another study found that TMP via intracranial administration was able to prevent the cognitive behavioral phenotype of diabetes by modulating the SIRT1/Nrf2/HO-1 pathway, increasing the concentrations of GSH and SOD, as well as decreasing the content of mitochondrial DNA in the hippocampus of STZ-AD mice (119).